The François Baclesse center launched in April 2020 a clinical study aimed at studying the impact of the COVID-19 epidemic on the care of patients with solid or hematological cancer, as well as its psychological consequences for patients and caregivers. The study included 735 patients and 73 caregivers (ongoing follow-up).
The Cancer and Cognition platform is involved in the study and will evaluate the psychological and cognitive impact as well as post-traumatic stress.
The COVIPACT study has already been the subject of several scientific articles or in the press:
- Press release of 23 November 2020
- Presentation of the study by the University of Caen
- Preliminary results presented at the ESMO virtual congress in September 2020 (Joly F, Leconte A, Grellard JM, et al. LBA69: impact of the COVID-19 pandemic on management of medical cancer treatments and psychological consequence for the patients. Ann Oncol . 2020; 31 (suppl 4): S1200. Doi: 10.1016 / j.annonc.2020.08.2310)
- Ouest France article of January 11, 2021
- Other scientific publications related to the study:
- Lange M, et al. Impact on mental health of the COVID-19 outbreak among community pharmacists during the sanitary lockdown period. Ann Pharm Fr (2020), https://doi.org/10.1016/j.pharma.2020.09.002
- Giffard B, Joly F. Impact psychologique de l’épidémie de Covid-19 et du confinement chez des patients pris en charge pour un cancer. Rev Neuropsychol 2020 ; 12 (2) : 193-5 doi:10.1684/nrp.2020.0569
